Viewing Study NCT05747794


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT05747794
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-17
First Post: 2023-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy
Sponsor: Immutep S.A.S.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module